SIX : ABT.SW

Abbott Laboratories

$72.5 CHF

-$2 (-2.68%)

Volume
5
Average Volume
1
Market Capitalization
$126.28B
P/E Ratio
33.63
Dividend Yield
2.37%
Price Target
Year High
$106.00
Year Low
$65.00
Day High
—
Day Low
—
Payout Ratio
$0.77
Current Ratio
$1.39
Company Overview

SIX

Robert Ford

Medical - Devices

Healthcare

ABT.SW

114000

US

CHF

https://www.abbott.com

224 667 6100

002824100

N/A

Liquidity Metrics

0.65

1.39

1.01

0.37

0.77

Sales & Valuation

$44.33B

3.91

3.50

24.69

4.23

Profitability

$3.73

$6.52B

11.65%

16.12%

10.55%

4.91%

P/E Metrics

33.63

-0.55

-0.55

Analyst Price Target & Rating

N/A

0/5

40 Analysts

%

Financial Health Scores

2.97

5/9

$7.11B

$110.16B

$57.59B

$7.67B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Erica L. Battaglia Vice President and Chief Ethics & Compliance Officer
Scott Michael Leinenweber Senior Vice President of Licensing, Acquisitions & Ventures
Lisa D. Earnhardt Executive Vice President & Group President of Medical Devices
Mary K. Moreland Executive Vice President of Human Resources
Daniel Gesua Sive Salvadori Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Philip Boudreau Chief Financial Officer & Executive Vice President of Finance
Michael Comilla Vice President of Investor Relations.
Robert Ford Executive Chairman, President & CEO
Melissa Brotz Senior Vice President of Global Marketing & External Affairs
Christopher J. Scoggins Executive Vice President of Diabetes Care
Elizabeth Cushman Executive Vice President, General Counsel & Secretary
Sabina Ewing Senior Vice President of Business & Technology Services and Chief Information Officer
Poll Results

No votes yet today — be the first to share your view!

About Abbott Laboratories (SIX:ABT.SW) Stock

Abbott Laboratories, a global healthcare company operating through its various subsidiaries, is committed to the research, development, production, and sale of a diverse portfolio of health-related products worldwide. Its operations are structured into four main divisions: The Established Pharmaceutical Products segment offers generic medications for a broad spectrum of conditions. These include treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis, depressive symptoms, gynecological disorders, and hormone replacement therapy. It also provides solutions for dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, as well as pain, fever, inflammation, and migraines. Key offerings further extend to the anti-infective ... clarithromycin, an influenza vaccine, and products designed to regulate the physiological rhythm of the colon. The Diagnostic Products segment delivers a comprehensive range of diagnostic tools and systems. This includes laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion medicine. It also features molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, alongside detecting and measuring infectious agents. Further offerings encompass point-of-care systems, blood test cartridges, rapid lateral flow testing products, and molecular point-of-care testing for various conditions like HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. The segment also supplies cardiometabolic test systems, drug and alcohol testing solutions, remote patient monitoring, consumer self-test systems, and advanced informatics and automation solutions for laboratory applications. The Nutritional Products division specializes in providing a variety of nutritional items for both children and adults. Finally, the Medical Devices segment develops and markets advanced medical technologies, primarily focusing on cardiovascular health with devices for rhythm management, electrophysiology, heart failure, vascular interventions, and structural heart conditions. This segment also offers diabetes care products and neuromodulation devices used in the management of chronic pain and movement disorders. Abbott Laboratories was established in 1888 and is headquartered in North Chicago, Illinois.

Frequently Asked Questions

What is the current Abbott Laboratories (ABT.SW) stock price?

Abbott Laboratories(SIX:ABT.SW) stock price is $72.5 in the last trading session. During the trading session, ABT.SW stock reached the peak price of $106 while $65 was the lowest point it dropped to. The percentage change in ABT.SW stock occurred in the recent session was --2.68% while the dollar amount for the price change in ABT.SW stock was -$2.

ABT.SW's industry and sector of operation?

The SIX listed ABT.SW is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of ABT.SW?

Erica L. Battaglia | Vice President and Chief Ethics & Compliance Officer
Scott Michael Leinenweber | Senior Vice President of Licensing, Acquisitions & Ventures
Lisa D. Earnhardt | Executive Vice President & Group President of Medical Devices
Mary K. Moreland | Executive Vice President of Human Resources
Daniel Gesua Sive Salvadori | Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

How many employees does ABT.SW have?

Number of ABT.SW employees currently stands at 114000. ABT.SW operates from 100 Abbott Park Road, North Chicago, IL 60064-6400, US.

Link for ABT.SW official website?

Official Website of ABT.SW is: https://www.abbott.com

How do I contact ABT.SW?

ABT.SW could be contacted at phone #224 667 6100 and can also be accessed through its website. ABT.SW operates from 100 Abbott Park Road, North Chicago, IL 60064-6400, US.

How many shares of ABT.SW are traded daily?

The average number of ABT.SW shares traded daily for last 3 months was 1.

What is the market cap of ABT.SW currently?

The market value of ABT.SW currently stands at $126.28B with its latest stock price at $72.5